Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEUCRAVACITINIB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

63.8%
Female
36.2%
Male

Age Information

The average age of patients reporting adverse events with DEUCRAVACITINIB is 56.8 years.

Geographic Distribution

The majority of adverse event reports for DEUCRAVACITINIB originate from US.

Report Summary & Outcomes

2,386
Total Reports
2,386
As Primary/Secondary Suspect
36
Deaths Reported
121
Hospitalizations
13
Life-Threatening
8
Disabilities

Reporting Timeline

First adverse event report: 20190702. Most recent report: 20250916. View full timeline →

More About DEUCRAVACITINIB

DEUCRAVACITINIB Full Profile Reports by Year Drug Interactions